Project Grant HT94252310565

Award Date 7/1/23
Completion Date 6/30/25
Dollars Obligated $250K
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
450 Serra Mall, Stanford, CA 94305, USA
Similar Awards
This Project Grant award of $999,983.00 from the Defense Health Agency supports research by The Leland Stanford Junior University (Stanford University) to analyze Epstein-Barr virus (EBV) genomes, epigenomes, and EBV-dependent B cell proteomes. The goal is to identify fundamental viral triggers of multiple sclerosis (MS). The 3-year project will run from July 1, 2023 to June 30, 2026. This award is funded through the Military Medical Research and Development program (CFDA 12.420), which supports...
This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,419,063.00 to The Leland Stanford Junior University (Stanford University) to conduct research on synaptic retinoic acid signaling in spinal cord homeostatic plasticity and mechanical allodynia. The research, which will take place at Stanford University from September 1, 2023 to August 31, 2027, aims to transform healthcare for U.S. Service Members and...
The U.S. Department of the Army Medical Command awarded The Leland Stanford Junior University (Stanford University) a $1,045,651 Project Grant on September 30, 2024 under the Military Medical Research and Development program (CFDA 12.420). The funding will support research to develop novel statistical methods for integrating high-dimensional clinical markers to evaluate treatment efficacy in amyotrophic lateral sclerosis (ALS) clinical trials. This research aims to transform health care for...
This $3,032,249 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports an integrated microbasophil activation test for accurate, safe, and accessible food allergy diagnostics. The award was made to The Leland Stanford Junior University, a renowned private research institution, with a performance period from September 30, 2023 to September 29, 2027. The project aims to develop innovative diagnostic solutions to...
The Defense Health Agency awarded The Leland Stanford Junior University a $1,500,084 project grant under the Military Medical Research and Development program to support research on detecting cartilage surface degeneration using photon counting CT and solute transport modeling. This grant will fund research from July 1, 2023 through June 30, 2027 aimed at transforming military and public health care through innovative medical solutions applicable to battlefield conditions. The Military Medical...
This federal Project Grant award, valued at $548,519.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Leland Stanford Junior University (Stanford University) to conduct research on targeting the RSK protein for the treatment of pediatric acute myeloid leukemia. The award period is from September 15, 2023, to September 14, 2026. As a leading research university, Stanford University has significant experience...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,191,941 to The Leland Stanford Junior University (Stanford University) from July 15, 2023 through July 14, 2027. The purpose of the grant is to conduct research on "Targeting Unusual Nutrient Acquisition Routes of Nutrient-Deprived Cancers." As a highly-regarded private research university, Stanford University has a history of providing...
The Leland Stanford Junior University has been awarded a $1,291,660.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on May 15, 2024, will fund foundational studies to understand phenotypic, region-specific, and cell-specific dysregulation in the myotonic dystrophy central nervous system, with a period of performance through May 14, 2028. This federal grant award supports the university's expertise in...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $1,795,499 project grant to The Leland Stanford Junior University, doing business as Stanford University, to conduct an evaluation of clinical responders with advanced triple-negative breast cancer from the KEYNOTE-890 study. The purpose of this 4-year project is to validate a published CXCR3 gene signature that may help identify patients likely to respond to certain cancer...
The U.S. Department of Defense's Defense Health Agency awarded a $250,000 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "EPSTEIN-BARR VIRUS IN PATIENTS WITH NEW-ONSET MULTIPLE SCLEROSIS". The project will run from July 1, 2024 to June 30, 2026. As a prime grantee, Yale University will lead this scientific research effort to advance knowledge about the relationship between Epstein-Barr virus and the...

The U.S. Defense Health Agency awarded a $250,000 Project Grant on July 1, 2023 to The Leland Stanford Junior University, also known as Stanford University, under the Military Medical Research and Development program (CFDA 12.420). The funding supports the isolation and engineering of potent anti-EBV neutralizing antibodies for the treatment of multiple sclerosis (MS). The project will be conducted at Stanford University's campus in Stanford, California over a 2-year period, ending on June 30, 2025. The goal is to develop antibody-based therapies that can neutralize the Epstein-Barr virus (EBV) and potentially treat the underlying drivers of MS.

Generated 4/9/24, 5:38 AM